Private Capital Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1K Sell
23
-50
-68% -$2.76K ﹤0.01% 1755
2022
Q1
$4K Hold
73
﹤0.01% 1615
2021
Q4
$4K Hold
73
﹤0.01% 1622
2021
Q3
$4K Hold
73
﹤0.01% 1663
2021
Q2
$4K Hold
73
﹤0.01% 1649
2021
Q1
$3K Hold
73
﹤0.01% 1671
2020
Q4
$3K Hold
73
﹤0.01% 1684
2020
Q3
$3K Hold
73
﹤0.01% 1627
2020
Q2
$3K Buy
73
+23
+46% +$920 ﹤0.01% 1621
2020
Q1
$2K Hold
50
﹤0.01% 1694
2019
Q4
$2K Hold
50
﹤0.01% 1711
2019
Q3
$2K Buy
50
+23
+85% +$758 ﹤0.01% 1914
2019
Q2
$1K Buy
+27
New +$802 ﹤0.01% 2057
2018
Q4
Sell
-27
Closed -$1K 2304
2018
Q3
$1K Hold
27
﹤0.01% 2084
2018
Q2
$1K Sell
27
-550
-95% -$18.5K ﹤0.01% 2033
2018
Q1
$19K Buy
577
+304
+111% +$11.7K ﹤0.01% 1093
2017
Q4
$28K Buy
+273
New +$12.4K 0.01% 929

Other funds holding PBH

Private Capital Group's PBH Position: Q2 2022 in Review

Private Capital Group reduced its Prestige Consumer Healthcare (PBH) stake by 68% in Q2 2022, selling an estimated $2.76K and leaving 23 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

Private Capital Group first reported a position in PBH in Q4 2017 and has held it in 17 quarters since. The position peaked at $28K in Q4 2017. 284 funds tracked by Wall St. Rank hold PBH as of Q2 2022.

  • Private Capital Group held 23 shares of Prestige Consumer Healthcare worth $1K as of Q2 2022.
  • Private Capital Group sold 50 Prestige Consumer Healthcare shares in Q2 2022, an estimated $2.76K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1755 holding.
  • Private Capital Group first reported a position in Prestige Consumer Healthcare in Q4 2017 and has held it in 17 quarters since.
  • Private Capital Group's Prestige Consumer Healthcare position peaked at $28K in Q4 2017.
  • 284 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.